Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

New anti-H. pylori agents in development at Mitsubishi Chemical

Aug. 17, 1998

AU-006, a novel quinoline derivative with potent antiulcer activity

Aug. 14, 1998

Anti-H. pylori agents disclosed by Takeda

Aug. 12, 1998

Salofalk approved in Canada for the treatment of Crohn's disease

Aug. 12, 1998

Positive results reported from phase II trials of Provir for the treatment of watery diarrhea

Aug. 12, 1998

New agents for treating constipation presented at IUPHAR meeting

Aug. 11, 1998

Proton pump inhibitor IY-81149 is active in models of acute and chronic gastric ulcers

Aug. 10, 1998

Rabeprazole and teprenone combination therapy effective for gastric ulcers

July 30, 1998

Intercardia signs license to develop drug for IBD

July 28, 1998

Synsorb announces commencement of U.S. phase II trials for CDAD Rx

July 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...